These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 6859073)
21. Loss of effectiveness of dihydralazine in the long-term treatment of chronic heart failure. Reifart N; Kaltenbach M; Bussmann WD Eur Heart J; 1984 Jul; 5(7):568-80. PubMed ID: 6479183 [TBL] [Abstract][Full Text] [Related]
22. Selection of vasodilator, inotropic or combined therapy for the management of heart failure. Cohn JN; Franciosa JA Am J Med; 1978 Jul; 65(1):181-8. PubMed ID: 685992 [TBL] [Abstract][Full Text] [Related]
23. Beneficial actions of nitrates in cardiovascular disease. Abrams J Am J Cardiol; 1996 May; 77(13):31C-7C. PubMed ID: 8638524 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography. Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789 [TBL] [Abstract][Full Text] [Related]
25. Hydralazine in heart failure. Chatterjee K Herz; 1983 Aug; 8(4):187-98. PubMed ID: 6413340 [TBL] [Abstract][Full Text] [Related]
26. Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial. Franciosa JA; Jordan RA; Wilen MM; Leddy CL Circulation; 1984 Jul; 70(1):63-8. PubMed ID: 6373050 [TBL] [Abstract][Full Text] [Related]
27. Effect of isosorbide dinitrate on cardiac output in severe cardiac failure: relation to initial hemodynamics, ventricular volume, and the preload reserve mechanism. Lewis BS; Hardoff R; Halon DA Clin Cardiol; 1989 Sep; 12(9):514-20. PubMed ID: 2791373 [TBL] [Abstract][Full Text] [Related]
28. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945 [TBL] [Abstract][Full Text] [Related]
29. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure. Packer M; Meller J; Medina N; Yushak M Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876 [TBL] [Abstract][Full Text] [Related]
30. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction. van Woerkens LJ; van der Giessen WJ; Verdouw PD Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521 [TBL] [Abstract][Full Text] [Related]
31. Nitrates versus angiotensin-converting enzyme inhibitors for congestive heart failure. Cohn JN Am J Cardiol; 1993 Sep; 72(8):21C-24C; discussion 24C-26C. PubMed ID: 8372797 [TBL] [Abstract][Full Text] [Related]
32. [Cardiac failure and nitrates]. Galinier M; Bounhoure JP Ann Cardiol Angeiol (Paris); 1997; 46(7):415-9. PubMed ID: 9452775 [TBL] [Abstract][Full Text] [Related]
33. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426 [TBL] [Abstract][Full Text] [Related]
34. Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure. Jezek V; Jezková J; Michaljanic A; Niederle P; Feuereisl R Eur Heart J; 1990 Dec; 11(12):1059-64. PubMed ID: 2292252 [TBL] [Abstract][Full Text] [Related]
35. Nitroglycerin and long-acting nitrates in clinical practice. Abrams J Am J Med; 1983 Jun; 74(6B):85-94. PubMed ID: 6407316 [TBL] [Abstract][Full Text] [Related]
36. Nitrates in congestive heart failure. Herman BM; Charlap S; Frishman WH Med Clin North Am; 1989 Mar; 73(2):361-71. PubMed ID: 2645481 [TBL] [Abstract][Full Text] [Related]
37. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure. Franciosa JA; Cohn JN Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762 [TBL] [Abstract][Full Text] [Related]
38. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance. Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013 [TBL] [Abstract][Full Text] [Related]
39. Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions. Stemple DR; Kleiman JH; Harrison DC Am J Cardiol; 1978 Aug; 42(2):267-75. PubMed ID: 685839 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective. Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]